Association Between Serum Asprosin, FABP4, and Vaspin Levels and Coronary Artery Disease in Patients with COPD

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is linked to systemic inflammatory activity and an increased burden of cardiovascular comorbidity, particularly coronary artery disease (CAD). This study aimed to examine serum asprosin, fatty acid-binding protein 4 (FABP4), and vaspin levels in COPD patients according to the presence or absence of CAD. MATERIAL AND METHODS: This prospective cross-sectional study included 120 participants: COPD (n = 40), COPD with CAD (n = 40), and healthy controls (n = 40). Serum biomarker levels were compared among groups. Receiver operating characteristic analysis and multivariable logistic regression were used to assess discriminative performance and independent associations. RESULTS: Biomarker levels differed significantly among groups ( P < 0.001). Median asprosin levels were 8.32, 14.98, and 11.88 ng/mL; median FABP4 levels were 205.86, 708.63, and 416.18 ng/L; and median vaspin levels were 4.37, 6.17, and 5.50 ng/mL in the COPD, COPD+CAD, and control groups, respectively. Area under the curve values were 0.898 for asprosin, 0.891 for vaspin, and 0.860 for FABP4 (all P < 0.001). After adjustment for age and low-density lipoprotein (LDL) cholesterol, asprosin [odds ratio (OR) 1.965, 95% confidence interval (CI) 1.436–2.691], FABP4 (OR 1.014, 95% CI 1.007–1.021), and vaspin (OR 2.896, 95% CI 1.767–4.745) remained independently associated with CAD (all P < 0.001). CONCLUSION: Serum asprosin, FABP4, and vaspin levels were elevated in COPD patients with CAD, and showed discriminative ability in this cohort, with each biomarker remaining associated with CAD after adjustment for age and LDL cholesterol. These findings require confirmation in larger prospective cohorts.

Authors

Institutions

Publication Details

Journal
Thoracic research and practice
Published
2026-11-18
DOI
https://doi.org/10.4274/thoracrespract.2026.2026-8-2
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association Between Serum Asprosin, FABP4, and Vaspin Levels and Coronary Artery Disease in Patients with COPD

Alperen Aksakal, Mustafa Buğra Coşkuner, Esra Laloğlu, Buğra Kerget et al.
Thoracic research and practice
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Association Between Serum Asprosin, FABP4, and Vaspin Levels and Coronary Artery Disease in Patients with COPD

Alperen Aksakal, Mustafa Buğra Coşkuner, Esra Laloğlu, Buğra Kerget, Leyla Sağlam, Burcu Nur Gülbahar
article en

Abstract

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is linked to systemic inflammatory activity and an increased burden of cardiovascular comorbidity, particularly coronary artery disease (CAD). This study aimed to examine serum asprosin, fatty acid-binding protein 4 (FABP4), and vaspin levels in COPD patients according to the presence or absence of CAD. MATERIAL AND METHODS: This prospective cross-sectional study included 120 participants: COPD (n = 40), COPD with CAD (n = 40), and healthy controls (n = 40). Serum biomarker levels were compared among groups. Receiver operating characteristic analysis and multivariable logistic regression were used to assess discriminative performance and independent associations. RESULTS: Biomarker levels differed significantly among groups ( P < 0.001). Median asprosin levels were 8.32, 14.98, and 11.88 ng/mL; median FABP4 levels were 205.86, 708.63, and 416.18 ng/L; and median vaspin levels were 4.37, 6.17, and 5.50 ng/mL in the COPD, COPD+CAD, and control groups, respectively. Area under the curve values were 0.898 for asprosin, 0.891 for vaspin, and 0.860 for FABP4 (all P < 0.001). After adjustment for age and low-density lipoprotein (LDL) cholesterol, asprosin [odds ratio (OR) 1.965, 95% confidence interval (CI) 1.436–2.691], FABP4 (OR 1.014, 95% CI 1.007–1.021), and vaspin (OR 2.896, 95% CI 1.767–4.745) remained independently associated with CAD (all P < 0.001). CONCLUSION: Serum asprosin, FABP4, and vaspin levels were elevated in COPD patients with CAD, and showed discriminative ability in this cohort, with each biomarker remaining associated with CAD after adjustment for age and LDL cholesterol. These findings require confirmation in larger prospective cohorts.

Thoracic research and practice
Aksaray University (TR), Erzurum Regional Training and Research Hospital (TR), Sağlık Bilimleri Üniversitesi (TR), Atatürk University (TR)
Good health and well-being
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon